| DRUG | SUPPLIED | DOSE | COMMENTS |
|---|---|---|---|
| ENOXAPARIN (Paeds) (Lovenox, low molecular weight heparin, LMWH) Mechanism of action: Low molecular weight heparin; Anticoagulant Ref: 90, 141, 149 Last update: 2019-01-25 |
Injection: 300 mg/3 mL multi-dose vial |
Treatment of thrombosis: <= 2 mo. of age: 1.5 mg/kg/dose SC Q12H >2 mo. of age: 1 mg/kg/dose SC Q12H DVT prophylaxis: reduce above dose by 50% or give 1 mg/kg/dose once daily Dose adjustment required in renal failure Round to the nearest mg if possible |
Hematology Consult suggested. See Protocols for Anticoagulant and Thrombolytic Therapy in Supplementary Materials and References for information on dosage adjustment, mechanism of action, administration and teaching. For doses less than 10 mg use 30 unit insulin syringe (1 U = 1 mg) to administer. Store vials at room temperature; 28 day expiry once opened. Hold 2 doses prior to any invasive procedure such as LP. Requires "Special Authority" from Pharmacare if prescribing for home use. Neonates may require higher dose. Standard Prescription: enoxaparin__mg SC Q__H (__mg/kg/dose) |